- Report
- January 2024
- 200 Pages
Global
From €4804EUR$5,000USD£4,131GBP
- Report
- December 2023
- 200 Pages
Global
From €4804EUR$5,000USD£4,131GBP
- Report
- December 2023
- 200 Pages
Global
From €4804EUR$5,000USD£4,131GBP
- Report
- May 2024
- 380 Pages
Global
From €5237EUR$5,450USD£4,503GBP
- Clinical Trials
- April 2024
- 40 Pages
Global
From €1201EUR$1,250USD£1,033GBP
- Report
- May 2024
- 194 Pages
From €3242EUR$3,374USD£2,788GBP
€3602EUR$3,749USD£3,097GBP
- Report
- June 2020
- 112 Pages
Global
From €4564EUR$4,750USD£3,924GBP
- Report
- June 2020
- 111 Pages
Global
From €4564EUR$4,750USD£3,924GBP
- Report
- May 2023
- 160 Pages
Global
From €5764EUR$5,999USD£4,956GBP
- Report
- May 2023
- 140 Pages
Global
From €5764EUR$5,999USD£4,956GBP
- Report
- March 2023
- 147 Pages
Global
From €5764EUR$5,999USD£4,956GBP
- Book
- February 2024
- 592 Pages
Benzodiazepines are a class of psychoactive drugs used to treat mental disorders such as anxiety, insomnia, and seizures. They act on the central nervous system to produce a calming effect, and are often prescribed to treat symptoms of anxiety, panic, and insomnia. Benzodiazepines are also used to treat alcohol withdrawal, muscle spasms, and seizures. They are generally considered to be safe and effective when used as prescribed, but can be habit-forming and have the potential for abuse.
Benzodiazepines are among the most commonly prescribed drugs in the world, and are widely used to treat a variety of mental health conditions. They are generally considered to be safe and effective when used as prescribed, but can be habit-forming and have the potential for abuse.
Some companies in the benzodiazepine market include Pfizer, GlaxoSmithKline, Sanofi, and Mylan. Show Less Read more